Study Objectives: New Orleans has both one of the nation's highest per capita murder rates and a population served by a single trauma center, University Medical Center (UMC). Since January 2014, CeaseFire New Orleans has employed a Hospital Crisis Intervention Team at UMC to respond 24/7 to shootings involving victims ages 16 to 25 years old. Hailing from the same communities as those most impacted by violent crime, CeaseFire staff interfaces with victims and their families in a culturally competent manner to prevent retaliatory violence. They also provide educational, employment, and mental health support to victims in an effort to break the cycle of violence. This study assesses the early impact of the CeaseFire New Orleans program, focusing on individual patient outcomes such as recidivism for major gunshot wounds (GSW).
Methods: A retrospective study of GSW victims was conducted using UMC trauma registry data from 2010-2017, focusing on men age 16 to 25 years old. We matched CeaseFire encounter forms to the trauma registry data to create 3 cohorts for the time period 2014-2017: those who accepted CeaseFire support and became program participants, those who were offered CeaseFire program participation but declined, and those not offered the intervention. Propensity score matching was used to minimize confounding variables among the groups. Additionally, we analyzed the groups from the perspective of having been a GSW victim prior to their index visit during the study period, and examined recidivism rates during the study period. Finally, we used survival analysis to evaluate the time to recidivism events.
Results: From 2010-2017, UMC saw 4197 patients with violent penetrating trauma; 2877 sustained major GSWs, of which 47.1% were 16 to 25 years old. In that age group, 89.8% were male and 95.8% were black. Within the study period, 8.8% of this age group had a recidivism event, compared with 6.6% for victims of all ages. From 2014-2017, CeaseFire enrolled 76 participants; 314 were offered the intervention and declined, and 161 were not offered the intervention. Recidivism rates among the 3 groups were roughly similar in the time period studied. Further analysis revealed that the CeaseFire participant group trended towards higher rates of GSWs suffered before the study index visit when compared to other groups, but their post-CeaseFire enrollment recidivism rates decreased to the overall group mean. Furthermore, participants had a mean 805 days (67 months) until a recidivism event if it occurred, compared with 682 days for those who declined the intervention and 693 days for those not offered the intervention (both 57 months).
Conclusions: CeaseFire appropriately targets the largest age demographic for major GSWs in New Orleans. This group was found to have a high incidence of GSWs prior to their index visit, as well as subsequent recidivism. Although recidivism rates in the intervention group were not significantly different than the other 2 groups, those in the intervention group who had a repeat major GSW had a longer time period until the event. As a preliminary assessment of the program, this data suggests promise of the CeaseFire New Orleans model, provides a temporal opportunity for further risk mitigation in this extremely high-risk population, and can guide continued implementation of the program. Further long-term studies are needed.
Predicting First Episodes of Non-Accidental Trauma With Machine Learning
Kim D, Cogill S, Yang S/Stanford University, Palo Alto, CA Study Objectives: Most current risk prediction tools are cross-sectional and static in nature, using a limited snapshot of patient characteristics to predict the likelihood of an adverse event. Our objective was to leverage advances in data science and machine learning to develop a general model of patients' health trajectories that can better predict rare adverse events like nonaccidental trauma (NAT), as well as identify optimal points for intervention in the ED.
Methods: We analyze a comprehensive statewide database of 74,554,047 ED visits from 2010-2015. We implement a word2vec model to represent all unique diagnoses made in California EDs in a space in which diagnoses are clustered on the likelihood of a patient receiving one diagnosis subsequently receiving another. We develop a recurrent neural network model of patients' trajectories through this "diagnosis space," using long short-term memory (LSTM) cells to explicitly model patients' sequences of diagnoses over time, and an "attention" mechanism to identify prognostically significant events in patients' trajectories. We train our model on the 75,550 California ED patients who received a first diagnosis of NAT in 2015, as well as on 200,000 patients who did not receive a diagnosis of NAT during the study period. We predict which patients will receive a first diagnosis of NAT at their next ED visit.
Results: The dataset contains 248,439,484 instances of 12,975 unique diagnoses made across 74,554,047 ED visits from 2010-2015. 1,017,736 visits represent NAT. The diagnosis space exhibits complex clustering among diagnoses, with prominent connections among traumatic and psychiatric diagnoses. Our model predicts first diagnoses of NAT with an AUC of 0.89, achieving 90% sensitivity at 67% specificity, and 100% sensitivity at 33% specificity. The model's attention layer identifies the specific events in each patient's trajectory that were most predictive of eventual NAT.
Conclusions: By modeling patient trajectories as a diagnosis space, to which modern deep learning methods can be applied, we identify, with high accuracy, ED patients at imminent risk of suffering NAT. Though we focus on NAT diagnoses, our method is general, and can be applied to predict any event of interest in patients' health trajectories. Whereas most deep learning models produce opaque predictions, from which the specific variables underlying correct predictions are difficult to derive, the attention mechanism of our model transparently identifies prognostically meaningful events and "critical periods" in patients' health trajectories, which can be used to target interventions at the point-of-care. Study Objectives: US guidelines recommend post-exposure rabies prophylaxis with 1 dose of rabies immune globulin within 7 days of exposure and 4 doses of the rabies vaccine over a 14-day period. Emergency department physicians should administer the rabies immune globulin and the first vaccine dose as soon as possible post exposure to patients who have not been fully immunized. This study aims to evaluate the population as well as the treatment patterns among patients seeking emergency services in the US due to recorded rabies exposures.
Rabies Exposures and Treatment in US Emergency Department Settings
Methods: A real world cross-sectional study using the 2006-2015 Nationwide Emergency Department Sample (NEDS) was conducted. Rabies exposure visits were selected using (ICD-9-CM): 71, V01.5, 99.44, V04.5 and V07.2 for years 2006 to Quarter 3 2015 and (ICD-10-CM): Z20.3, Z23, Z29.11, A82,Z20.9, Z29.14, W54, W55 for Quarter 4 2015. Visits were stratified by treatment status using CPT codes representing human rabies immune globulin (HRIG) (CPT: 90375, 90376) and vaccine (CPT: 90675, 90676) . Visits were further stratified by pediatric and adult age groups (0-17 years/18+years).
Results: During the 10-year study duration, 118,710 ED visits were recorded as rabies exposures. 51.5% of these exposures were reported in northeastern US while 30.5% occurred in the south. 81% of visits were to Metropolitan area hospitals and 52.7% of the exposure patients were female. Mean age of the exposed cohort was 33.5 years with 32.2% being under the age of 18 (children).
Of the 118,710 reported rabies exposures in the NEDS database, over threequarters (76.5%) did not receive any rabies treatment in the emergency department. Of the 23% of exposures who did receive treatment, 17.2% received HRIG, 82.8% received a vaccine, with only 14.7% receiving both HRIG and a vaccine. Commercially insured patients were more likely to receive treatment than those in other primary payer groups, and those visiting a large metropolitan area hospital also had a higher likelihood of receiving rabies treatment than patients in other hospital types.
The treated group was slightly younger than their non-treated counterparts (32.2 versus 33.9 years, SD¼20.7; p<0.0001). However, when comparing treatment patterns of adults versus children, 4.4% of children versus 3.9% of adults received HRIG, 19.1% versus 19.6% received a vaccine, while 16.3% versus 13.9% received the combination.
Conclusions: How rabies "exposures" are defined and reported is controversial which is evident by the 76% of untreated rabies encounters in this study. However, this real world retrospective study clearly demonstrates
